Pfizer to launch Lyrica DTC

Share this article:
Pfizer plans to launch DTC promoting Lyrica for fibromyalgia in the fall, just five months after gaining approval for the condition under its "fast to market" strategy, the Pink Sheet reports.  

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions